p. 15919−15924
2345-5055
Vol.10/No.5
p. 15925−15936
2345-5055
Vol.10/No.5
150 ng/ml were found exclusively in patients with allergic diseases 22/40 (55.00%) and only in 4/40 (10.0%) of the controls (p-value<0.0001). Furthermore, there were a statistically significant difference between the patients with different degrees of allergic diseases severity and serum periostin level as it was 1080±251.73 ng/ml in severe allergic diseases compared to 244.5±263.57 ng/ml in mild allergic diseases (P- value 0.01).Conclusion: The most common type of allergic diseases in our study was bronchial asthma. Higher serum periostin levels were observed in allergic patients in comparison to the controls; and they were found to have a significant relationship with disease severity.]]>
p. 15937−15944
2345-5055
Vol.10/No.5
p. 15945−15956
2345-5055
Vol.10/No.5
p. 15957−15971
2345-5055
Vol.10/No.5
p. 15972−15981
2345-5055
Vol.10/No.5
p. 15982−15991
2345-5055
Vol.10/No.5
0.05).Conclusion: Beraksurf seems to be as effective as curosurf in premature neonates with RDS, but is less expensive than it.]]>
p. 15992−15997
2345-5055
Vol.10/No.5
A mutation in the exon 15 of DNMT3B. With respect to the diagnosis of ICF syndrome, our patient was treated with intravenous immunoglobulin (IVIG).Conclusion: It is necessary to perform periodic neurologic and ophthalmologic examinations. Echocardiography must be done annually. In addition, the possibility of HSCT should be evaluated]]>
p. 15998−16004
2345-5055
Vol.10/No.5
p. 16005−16016
2345-5055
Vol.10/No.5
0.05). The findings showed that most of the mothers' beliefs about the outcomes of exclusive breastfeeding (increased emotional bond between the mother and the infant, growth and strength of infant's bones and teeth, and infant's immunity to diseases such as diarrhea) were significant (P< 0.05).Conclusions: When designing interventions, efforts should be made to create and maintain a positive attitude toward exclusive breastfeeding through the promotion of behavioral beliefs and evaluation of behavioral outcomes.]]>
p. 16017−16027
2345-5055
Vol.10/No.5
p. 16028−16046
2345-5055
Vol.10/No.5
p. 16047−16057
2345-5055
Vol.10/No.5
p. 16058−16067
2345-5055
Vol.10/No.5
p. 16068−16081
2345-5055
Vol.10/No.5
p. 16082−16100
2345-5055
Vol.10/No.5
p. 16101−16111
2345-5055
Vol.10/No.5
p. 16112−16120
2345-5055
Vol.10/No.5